Reassessment of the role of aromatic amino acid hydroxylases and the effect of infection by Toxoplasma gondii on host dopamine

Infection and Immunity

Volumn 83, Issue 3, 2015, Pages 1039-1047

  Wang, Zi T ^a   Harmon, Steve ^b   O'Malley, Karen L ^b   Sibley, L David ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; OXYGENASE; ISOENZYME; MIXED FUNCTION OXIDASE; PROTOZOAL PROTEIN;

ARTICLE; BRADYZOITE; BRAIN CYST; CHROMOSOME; CONTROLLED STUDY; CROSS REACTION; DISEASE TRANSMISSION; DOPAMINE BRAIN LEVEL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMOLOGOUS RECOMBINATION; HOST; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LIMIT OF DETECTION; MOUSE; NONHUMAN; PC12 CELL LINE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FOLDING; REAL TIME POLYMERASE CHAIN REACTION; SEROCONVERSION; TACHYZOITE; TOXOPLASMOSIS; WESTERN BLOTTING; ANIMAL; ANIMAL TOXOPLASMOSIS; BRAIN; CAT; DEFICIENCY; ENZYMOLOGY; GENE DELETION; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PARASITE INTERACTION; LIFE CYCLE STAGE; METABOLISM; PARASITOLOGY; PLASMID; TOXOPLASMA;

ANIMALS; BRAIN; CATS; DOPAMINE; FEMALE; GENE DELETION; GENE EXPRESSION; HOST-PARASITE INTERACTIONS; ISOENZYMES; LIFE CYCLE STAGES; MICE; MIXED FUNCTION OXYGENASES; PLASMIDS; PROMOTER REGIONS, GENETIC; PROTOZOAN PROTEINS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

EID: 84923006085     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02465-14     Document Type: Article

References (47)

1. Dubey JP. 2007. The history and life cycle of Toxoplasma gondii, p 1-17. In Weiss LM, Kim K (ed), Toxoplasma gondii the model Apicomplexan: perspectives and methods. Academic Press, Elsevier, New York, NY.
2. Frenkel JK, Dubey JP, Miller NL. 1970. Toxoplasma gondii in cats: fecal stages identified as coccidian oocysts. Science 167:893-896. http://dx.doi.org/10.1126/science.167.3919.893.
3. Dubey JP, Thulliez P. 1993. Persistence of tissue cysts in edible tissues of cattle fed Toxoplasma gondii oocysts. Am J Vet Res 54:270-273.
4. Dubey JP, Dubey JP. 2010. Toxoplasmosis of animals and humans, 2nd ed. CRC Press, Boca Raton, FL.
5. Kaushik M, Knowles SC, Webster JP. 2014. What makes a feline fatal in Toxoplasma gondii's fatal feline attraction? Infected rats choose wild cats. Integr Comp Biol 54:118-128. http://dx.doi.org/10.1093/icb/icu060.
6. Kaushik M, Lamberton PH, Webster JP. 2012. The role of parasites and pathogens in influencing generalised anxiety and predation-related fear in the mammalian central nervous system. Hormones Behav 62:191-201. http://dx.doi.org/10.1016/j.yhbeh.2012.04.002.
7. Lamberton PH, Donnelly CA, Webster JP. 2008. Specificity of the Toxoplasma gondii-altered behaviour to definitive versus non-definitive host predation risk. Parasitology 135:1143-1150. http://dx.doi.org/10.1017/S0031182008004666.
8. Vyas A, Kim KS, Giacomini N, Boothroyd JC, Sapolsky RM. 2007. Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc Natl Acad Sci USA 104:6442-6447. http://dx.doi.org/10.1073/pnas.0608310104.
9. Berdoy M, Webster JP, Macdonald DW. 2000. Fatal attraction in rats infected with Toxoplasma gondii. Proc R Soc Lond B Biol Sci 267:1591-1594. http://dx.doi.org/10.1098/rspb.2000.1182.
10. Kannan G, Moldovan K, Xiao JC, Yolken RH, Jones-Brando L, Pletnikov MV. 2010. Toxoplasma gondii strain-dependent effects on mouse behaviour. Folia Parasitol 57:151-155. http://dx.doi.org/10.14411/fp.2010.019.
11. Golcu D, Gebre RZ, Sapolsky RM. 2014. Toxoplasma gondii influences aversive behaviors of female rats in an estrus cycle dependent manner. Physiol Behav 135:98-103. http://dx.doi.org/10.1016/j.physbeh.2014.05.036.
12. Xiao J, Kannan G, Jones-Brando L, Brannock C, Krasnova IN, Cadet JL, Pletnikov M, Yolken RH. 2012. Sex-specific changes in gene expression and behavior induced by chronic Toxoplasma infection in mice. Neuroscience 206:39-48. http://dx.doi.org/10.1016/j.neuroscience.2011.12.051.
13. Ingram WM, Goodrich LM, Robey EA, Eisen MB. 2013. Mice infected with low-virulence strains of Toxoplasma gondii lose their innate aversion to cat urine, even after extensive parasite clearance. PLoS One 8:e75246. http://dx.doi.org/10.1371/journal.pone.0075246.
14. Webster JP, McConkey GA. 2010. Toxoplasma gondii-altered host behaviour: clues as to mechanism of action. Folia Parasitol 57:95-104. http://dx.doi.org/10.14411/fp.2010.012.
15. Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, McConkey GA. 2011. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One 6:e23866. http://dx.doi.org/10.1371/journal.pone.0023866.
16. Skallova A, Kodym P, Frynta D, Flegr J. 2006. The role of dopamine in Toxoplasma-induced behavioural alterations in mice: an ethological and ethopharmacological study. Parasitology 133:525-535. http://dx.doi.org/10.1017/S0031182006000886.
17. Stibbs HH. 1985. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol 79:153-157.
18. Jones-Brando L, Torrey EF, Yolken R. 2003. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res 62:237-244. http://dx.doi.org/10.1016/S0920-9964(02)00357-2.
19. Webster JP, Lamberton PH, Donnelly CA, Torrey EF. 2006. Parasites as causative agents of human affective disorders? The impact of antipsychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc Biol Sci 273:1023-1030. http://dx.doi.org/10.1098/rspb.2005.3413.
20. Gaskell EA, Smith JE, Pinney JW, Westhead DR, McConkey GA. 2009. A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PLoS One 4:e4801. http://dx.doi.org/10.1371/journal.pone.0004801.
21. Fox BA, Falla A, Rommereim LM, Tomita T, Gigley JP, Mercier C, Cesbron-Delauw MF, Weiss LM, Bzik DJ. 2011. Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection. Eukaryot Cell 10:1193-1206. http://dx.doi.org/10.1128/EC.00297-10.
22. Lunde MN, Jacobs L. 1964. Properties of Toxoplasma Lysates Toxic to Rabbits on Intravenous Injection. J Parasitol 50:49-51.
23. Sibley LD, Boothroyd JC. 1992. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 359:82-85.
24. Bastin P, Bagherzadeh Z, Matthews KR, Gull K. 1996. A novel epitope tag system to study protein targeting and organelle biogenesis in Trypanosoma brucei. Mol Biochem Parasitol 77:235-239.
25. Donald RGK, Roos DS. 1998. Gene knock-outs and allelic replacements in Toxoplasma gondii: HXGPRT as a selectable marker for hit-and-run mutagenesis. Mol Biochem Parasitol 91:295-305.
26. Pfefferkorn ER, Bzik DJ, Honsinger CP. 2001. Toxoplasma gondii: mechanism of the parasitostatic action of 6-thioxanthine. Exp Parasitol 99:235-243. http://dx.doi.org/10.1006/expr.2001.4673.
27. Fux B, Nawas J, Khan A, Gill DB, Su C, Sibley LD. 2007. Toxoplasma gondii strains defective in oral transmission are also defective in developmental stage differentiation. Infect Immun 75:2580-2590. http://dx.doi.org/10.1128/IAI.00085-07.
28. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta-delta C(T)) method. Methods 25:402-408. http://dx.doi.org/10.1006/meth.2001.1262.
29. Shen B, Sibley LD. 2014. Toxoplasma aldolase is required for metabolism but dispensable for host-cell invasion. Proc Natl Acad SciUS A 111:3567-3572. http://dx.doi.org/10.1073/pnas.1315156111.
30. Lotharius J, O'Malley KL. 2000. The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J Biol Chem 275:38581-38588. http://dx.doi.org/10.1074/jbc.M005385200.
31. Soête M, Camus D, Dubremetz JF. 1994. Experimental induction of bradyzoite-specific antigen expression and cyst formation by the RH strain of Toxoplasma gondii in vitro. Exp Parasitol 78:361-370.
32. Boothroyd JC, Black M, Bonnifoy S, Hehl A, Knoll L, Manger ID, Ortega-Barria E, Tomavo S. 1997. Genetic and biochemical analysis of development in Toxoplasma gondii. Philos Trans R Soc Lond 352:1347-1354.
33. Behnke M, Wooten JC, Lehmann M, Radke J, Lucas O, Nawas J, Sibley LD, White M. 2010. Coordinated progression through two subtranscriptions underlies the tachyzoite cycle of Toxoplasma gondii. PLoS One 5:e12354. http://dx.doi.org/10.1371/journal.pone.0012354.
34. Bohne W, Gross U, Ferguson DJP, Hessemann J. 1995. Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants. Mol Microbiol 16:1221-1230.
35. Xiao J, Li Y, Prandovszky E, Karuppagounder SS, Talbot CC, Jr, Dawson VL, Dawson TM, Yolken RH. 2014. MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway. Neuroscience 268:128-138. http://dx.doi.org/10.1016/j.neuroscience.2014.03.015.
36. Goodwin D, Hrubec TC, Klein BG, Strobl JS, Werre SR, Han Q, Zajac AM, Lindsay DS. 2012. Congenital infection of mice with Toxoplasma gondii induces minimal change in behavior and no change in neurotransmitter concentrations. J Parasitol 98:706-712. http://dx.doi.org/10.1645/GE-3068.1.
37. Gatkowska J, Wieczorek M, Dziadek B, Dzitko K, Dlugonska H. 2013. Sex-dependent neurotransmitter level changes in brains of Toxoplasma gondii infected mice. Exp Parasitol 133:1-7. http://dx.doi.org/10.1016/j.exppara.2012.10.005.
38. Shen B, Brown KM, Lee TD, Sibley LD. 2014. Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9. mBio 5:e01114-14. http://dx.doi.org/10.1128/mBio.01114-14.
39. Andenmatten N, Egarter S, Jackson AJ, Jullien N, Herman JP, Meissner M. 2012. Conditional genome engineering in Toxoplasma gondii uncovers alternative invasion mechanisms. Nat Methods 10:125-127. http://dx.doi.org/10.1038/nmeth.2301.
40. Belli SI, Wallach MG, Luxford C, Davies MJ, Smith NC. 2003. Roles of tyrosine-rich precursor glycoproteins and dityrosine-and 3, 4-dihydroxyphenylalanine-mediated protein cross-linking in development of the oocyst wall in the coccidian parasite Eimeria maxima. Eukaryot Cell 2:456-464. http://dx.doi.org/10.1128/EC.2.3.456-464.2003.
41. Belli SI, Wallach MG, Smith NC. 2003. Cloning and characterization of the 82 kDa tyrosine-rich sexual stage glycoprotein, GAM82, and its role in oocyst wall formation in the apicomplexan parasite, Eimeria maxima. Gene 307:201-212. http://dx.doi.org/10.1016/S0378-1119(03)00451-7.
42. Fritz HM, Buchholz KR, Chen X, Durbin-Johnson B, Rocke DM, Conrad PA, Boothroyd JC. 2012. Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. PLoS One 7:e29998. http://dx.doi.org/10.1371/journal.pone.0029998.
43. Wang Q, Hauser V, Read M, Wang P, Hanson AD, Sims PF, Hyde JE. 2006. Functional identification of orthologous genes encoding pterin recycling activity in Plasmodium falciparum and Toxoplasma gondii. Mol Biochem Parasitol 146:109-112. http://dx.doi.org/10.1016/j.molbiopara.2005.11.002.
44. Revankar SG, Sutton DA. 2010. Melanized fungi in human disease. Clin Microbiol Rev 23:884-928. http://dx.doi.org/10.1128/CMR.00019-10.
45. Munoz M, Liesenfeld O, Heimesaat MM. 2011. Immunology of Toxoplasma gondii. Immunol Rev 240:269-285. http://dx.doi.org/10.1111/j.1600-065X.2010.00992.x.
46. Haroon F, Handel U, Angenstein F, Goldschmidt J, Kreutzmann P, Lison H, Fischer KD, Scheich H, Wetzel W, Schluter D, Budinger E. 2012. Toxoplasma gondii actively inhibits neuronal function in chronically infected mice. PLoS One 7:e35516. http://dx.doi.org/10.1371/journal.pone.0035516.
47. Evans AK, Strassmann PS, Lee IP, Sapolsky RM. 2014. Patterns of Toxoplasma gondii cyst distribution in the forebrain associate with individual variation in predator odor avoidance and anxiety-related behavior in male Long-Evans rats. Brain Behav Immun 37:122-133. http://dx.doi.org/10.1016/j.bbi.2013.11.012.